Loading company…
Quotient Diagnostics develops testing technology for the diagnosis, treatment and management of diabetes.
Quotient Diagnostics develops testing technology for diabetes and associated diseases, covering diagnosis, treatment and management. Founded in 2002 and based in the UK, the company is at the Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in